Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
AbbVie Inc stock faces renewed scrutiny as Mercy Investment files shareholder proposal amid pipeline and patent pressures
Mercy Investment has filed a shareholder proposal with AbbVie Inc., urging the pharmaceutical giant to enhance its focus on pipeline sustainability and capital allocation amidst patent battles and market dynamics for its immunology and oncology portfolios. This move is particularly relevant for US investors, as it signals potential governance shifts impacting the company’s core successor drugs to Humira. AbbVie’s pipeline execution risks and its defensive dividend profile are highlighted as key considerations for investors in the volatile biotech landscape.